Alaunos Therapeutics, Inc. (TCRT) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -1.03M | -552K | -844K | -701K | -772K | -592K | -781K | -1.68M | -1.92M | -7.38M | -6.37M | -7M | -9.38M | -7.13M | -6.14M | -8.19M | -7.77M | -15.13M | -9.58M | -21.45M |
| Operating CF Margin % | - | -18400% | - | - | -38600% | -14800% | - | -42025% | -191700% | -738500% | - | -175050% | - | -64818.18% | -211.1% | - | - | - | -2406.28% | - |
| Operating CF Growth % | -33.55% | 6.76% | -8.07% | 58.3% | 59.73% | 91.98% | 87.75% | 75.99% | 79.57% | -3.58% | -3.73% | 14.47% | -20.73% | 52.86% | 35.84% | 61.84% | 49.26% | 11.21% | 40.39% | -53.16% |
| Net Income | -1.01M | -893K | -1.16M | -1.05M | -1.07M | -742K | -1.13M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M | -22.67M |
| Depreciation & Amortization | 8K | 7K | 0 | 0 | 0 | -1K | 0 | 1K | 2K | 241K | 679K | 699K | 696K | 694K | 691K | 685K | 689K | 705K | 673K | 679K |
| Stock-Based Compensation | 56K | 35K | 127K | 184K | 68K | 81K | 80K | 102K | 172K | 250K | 726K | 914K | 910K | 877K | 808K | 990K | 853K | 917K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.01M | 10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 85K | 208K | 174K | 31K | 0 | 0 | 0 | 1K | 0 | 2.69M | 385K | 1.46M | 585K | 465K | 339K | 2.27M | 198K | 975K | 2.52M | 5.29M |
| Working Capital Changes | -174K | 91K | 14K | 135K | 233K | 70K | 266K | -656K | -409K | -2.72M | -701K | -1.31M | -1.52M | -7K | 868K | -2.2M | 278K | -5.93M | 9.96M | -4.75M |
| Change in Receivables | 3K | -3K | 2K | 0 | 3K | -5K | 4K | -3K | 0 | -1K | 4K | -4K | 4K | 2.91M | -2.91M | 1.11M | 1.11M | 400K | 6.12M | -2.62M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4K | 4K | 0 | 0 | 2.91M | 0 | -1.11M | 0 | 0 | 0 |
| Change in Payables | -212K | -230K | 34K | -22K | 315K | 59K | 92K | -232K | -19K | -681K | -182K | 200K | -110K | -641K | 1.51M | -131K | -763K | -229K | 481K | -2.63M |
| Cash from Investing | 0 | -1K | -97K | 0 | 0 | 0 | 0 | 0 | 0 | 1.5M | 1K | -135K | -23K | -93K | -14K | -57K | -29K | -359K | -370K | -1.88M |
| Capital Expenditures | 0 | -1K | -97K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | -135K | -61K | -116K | -14K | -57K | -29K | -359K | -370K | -1.88M |
| CapEx % of Revenue | - | 33.33% | - | - | - | - | - | - | - | - | - | 3375% | - | 1054.55% | 0.48% | - | - | - | 92.96% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.5M | 2K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38K | 23K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | 3.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.98M | -6.16M | 8.47M | -2.11M | 0 | 0 | -186K | 24.93M | 19K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 125K | 0 | -11.86M | -6.25M | -6.25M | -2.08M | 0 | 0 | -185K | 24.93M | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 3.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92K | 14.72M | -45K | 0 | 0 | -1K | 1K | 19K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -125K | 0 | -125K | 0 | 0 | 21K | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -1.03M | -553K | -941K | 2.56M | -772K | -592K | -780K | -1.68M | -1.92M | -5.88M | -6.37M | -19.12M | -15.56M | 1.25M | -8.27M | -8.24M | -7.8M | -15.67M | 14.98M | -23.31M |
| Free Cash Flow | -1.03M | -553K | -941K | -701K | -772K | -592K | -781K | -1.68M | -1.92M | -7.38M | -6.38M | -7.14M | -9.44M | -7.25M | -6.16M | -8.24M | -7.8M | -15.48M | -9.95M | -23.33M |
| FCF Margin % | - | -18433.33% | - | - | -38600% | -14800% | - | -42025% | -191700% | -738500% | - | -178425% | - | -65872.73% | -211.58% | - | - | - | -2499.25% | - |
| FCF Growth % | -33.55% | 6.59% | -20.49% | 58.3% | 59.73% | 91.98% | 87.75% | 76.45% | 79.7% | -1.92% | -3.51% | 13.43% | -21.07% | 53.21% | 38.08% | 64.66% | 51.35% | 25.56% | 44.97% | -33.36% |
| FCF per Share | -0.53 | -0.28 | -0.43 | -0.42 | -0.48 | -0.37 | -0.49 | -1.05 | -1.20 | -4.61 | -3.98 | -4.46 | -5.91 | -4.87 | -4.30 | -5.75 | -5.44 | -10.82 | -6.95 | -16.32 |
| FCF Conversion (FCF/Net Income) | 1.02x | 0.62x | 0.73x | 0.67x | 0.72x | 0.80x | 0.69x | 1.49x | 1.14x | 0.94x | 0.75x | 0.80x | 0.93x | 0.78x | 0.69x | 0.82x | 0.79x | 1.28x | 0.42x | 0.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 439K | 568K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |